Paragon 28 To Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
February 06 2024 - 3:05PM
Business Wire
Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical
device company exclusively focused on the foot and ankle orthopedic
market, announced it will report financial results for the fourth
quarter and full year 2023 after market close on Thursday, February
29, 2024. The company’s management will webcast a corresponding
conference call beginning at 4:30 p.m. Eastern Time / 2:30 p.m.
Mountain Time.
Investors interested in listening to the conference call may do
so by dialing (833-470-1428) for domestic callers or (404-975-4839)
for international callers, using conference ID: 593140. Live audio
of the webcast will be available on the “Investors” section of the
company’s website at: ir.paragon28.com. The webcast will be
archived and available for replay for at least 90 days after the
event.
About Paragon 28, Inc.
Based in Englewood, Colo., Paragon 28, is a leading medical
device company exclusively focused on the foot and ankle orthopedic
market and is dedicated to improving patient lives. From the onset,
Paragon 28® has provided innovative orthopedic solutions,
procedural approaches and instrumentation that cover a wide range
of foot and ankle ailments including fracture fixation, forefoot,
ankle, progressive collapsing foot deformity (PCFD) or flatfoot,
charcot foot and orthobiologics. The company designs products with
both the patient and surgeon in mind, with the goal of improving
outcomes, reducing ailment recurrence and complication rates, and
making the procedures simpler, consistent, and reproducible.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240206432009/en/
Investor Contact: Matthew Brinckman Senior Vice
President, Strategy and Investor Relations Phone: (720) 912-1332
mbrinckman@paragon28.com
Paragon 28 (NYSE:FNA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Paragon 28 (NYSE:FNA)
Historical Stock Chart
From Sep 2023 to Sep 2024